4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-021166
Director sold 5,000 shares at $15.41 ($77,050)
- Director acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CHESS ROBERT · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-03-14 | Exercise or conversion : show line 1 in the form | +5,000 | $8.37 | $41,850 | 276,623 | D |
| 2017-03-14 | Sale : show line 2 in the form | −5,000 | $15.41 | $77,050 | 271,623 | D |
| Open-market sales · 5,000 sh · avg $15.41 · $77,050 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-03-14 | Exercise or conversion : show line 3 in the form Stock Option | −5,000 | $8.37 | 2017-09-14 | 5,000 | 10,000 | D |
Loading xslF345X03/doc4.xml…